225 related articles for article (PubMed ID: 30385835)
1. Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.
Mohler JL; Halabi S; Ryan ST; Al-Daghmin A; Sokoloff MH; Steinberg GD; Sanford BL; Eastham JA; Walther PJ; Morris MJ; Small EJ
Prostate Cancer Prostatic Dis; 2019 May; 22(2):309-316. PubMed ID: 30385835
[TBL] [Abstract][Full Text] [Related]
2. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
3. Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer.
Seabra D; Faria E; Dauster B; Rodrigues G; Fava G
Int Braz J Urol; 2009; 35(1):43-8. PubMed ID: 19254397
[TBL] [Abstract][Full Text] [Related]
4. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
Chade DC; Eastham J; Graefen M; Hu JC; Karnes RJ; Klotz L; Montorsi F; van Poppel H; Scardino PT; Shariat SF
Eur Urol; 2012 May; 61(5):961-71. PubMed ID: 22280856
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of salvage radical prostatectomy following more than one failed local therapy.
Sivaraman A; Scardino P; Eastham J
Investig Clin Urol; 2018 May; 59(3):152-157. PubMed ID: 29744471
[TBL] [Abstract][Full Text] [Related]
6. [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
Vidmar R; Marcq G; Flamand V; Fantoni JC; Hénon F; Villers A; Ouzzane A
Prog Urol; 2017; 27(8-9):458-466. PubMed ID: 28576424
[TBL] [Abstract][Full Text] [Related]
7. Seminal vesicle involvement at salvage radical prostatectomy.
Meeks JJ; Walker M; Bernstein M; Eastham JA
BJU Int; 2013 Jun; 111(8):E342-7. PubMed ID: 23495695
[TBL] [Abstract][Full Text] [Related]
8. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
9. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
Heidenreich A; Richter S; Thüer D; Pfister D
Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
[TBL] [Abstract][Full Text] [Related]
10. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results.
Kaouk JH; Hafron J; Goel R; Haber GP; Jones JS
BJU Int; 2008 Jul; 102(1):93-6. PubMed ID: 18410443
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy.
Song W; Jeon HG; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
Int J Urol; 2016 Jan; 23(1):56-61. PubMed ID: 26502086
[TBL] [Abstract][Full Text] [Related]
12. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL
Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085
[No Abstract] [Full Text] [Related]
13. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S
Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475
[TBL] [Abstract][Full Text] [Related]
14. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
15. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
[TBL] [Abstract][Full Text] [Related]
16. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
Mandel P; Steuber T; Ahyai S; Kriegmair M; Schiffmann J; Boehm K; Heinzer H; Michl U; Schlomm T; Haese A; Huland H; Graefen M; Tilki D
BJU Int; 2016 Jan; 117(1):55-61. PubMed ID: 25711672
[TBL] [Abstract][Full Text] [Related]
17. Salvage radical prostatectomy: an alternative treatment for local recurrence of radioresistant cancer.
Dall'Oglio MF; Barreto F; Paranhos M; Nesrallah A; Nesrallah L; Srougi M
Int Braz J Urol; 2006; 32(5):550-6. PubMed ID: 17081323
[TBL] [Abstract][Full Text] [Related]
18. [Salvage radical prostatectomy].
Hautmann RE
Urologe A; 2006 Oct; 45(10):1260-5. PubMed ID: 16983529
[TBL] [Abstract][Full Text] [Related]
19. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
Gomez-Veiga F; Mariño A; Alvarez L; Rodriguez I; Fernandez C; Pertega S; Candal A
BJU Int; 2012 Feb; 109 Suppl 1():17-21. PubMed ID: 22239225
[TBL] [Abstract][Full Text] [Related]
20. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]